2022 International Congress Archives - Page 45 of 153

Deterioration in Wilson’s Disease despite treatment. Are the neuroimaging findings useful as prognostic factor?

E. Urrea-Mendoza, S. Zaheer, F. Revilla (Greenville, USA)
Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)
Determination of glycine transporter 1 levels with [3H]-NFPS binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia

I. Frouni, D. Bédard, E. Kim, S. Belliveau, C. Kwan, P. Huot (Montreal, Canada)
Determination of metabotropic glutamate receptor 2/3 distribution with [3H]-LY-341,495 in Parkinson’s disease patients with visual hallucinations

D. Bedard, E. Kim, I. Frouni, P. Huot (Montreal, Canada)
Developing infrastructure for a multi-arm multi-stage trial in Parkinson’s

M-L. Zeissler, J. Allison, D. Athauda, S. Bartolomeu Pires, G. Baxendale, K. Bhatia, D. Breen, R. Chapman, H. Collins, R. Croucher, R. Ellis-Doyle, C. Gonzales-Robles, F. Hudson, R. Khengar, P. Korlipara, C. Lambert, G. Mills, A. Morgan, H. Morris, J. Rudiger, M. Silverdale, S. Wonnacott, A. Yarnall, T. Foltynie, C. Carroll, S. Mullin (Plymouth, United Kingdom)
Developing New Insights Into Clinical and Genetic Features of PD – The Global Parkinson’s Genetics Program (GP2) Clinical Cohorts Working Group

M. Richer, C. Towns, A. Martinez-Carrasco, J. Solle, A. Singleton, C. Blauwendraat, M. Tan, H. Iwaki, D. Vitale, Y. Song, M. Nalls, T. Antar, H. Morris (London, United Kingdom)
Developing zebrafish CRISPR/Cas9 knockout models of Parkinson’s Disease to identify novel therapeutic targets.

J. García-Fernández, L. López-Blanch, M. Irimia, F. de Santis, J. Terriente (Badalona, Spain)
Development and validation of clinical scales for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium

A. Busicescu (Phoenix, USA)
Development of a Novel Questionnaire on Women’s Health to Understand Its Role in Parkinson’s Disease Development and Progression

S. Rao, N. Gutierrez, A. Naito, K. Ghosh, B. Lapin, M. de Leon, I. Mata (Cleveland, USA)
Development of a patient journey map for people living with cervical dystonia

M. Benson, A. Albanese, K. Bhatia, P. Cavillon, L. Cuffe, K. König, C. Reinhard, H. Graessner (Brussels, Belgium)